Equity-informative economic evaluation of respiratory syncytial virus vaccination in older adults
| Duration | 2 years |
| Lead investigator | Anthony Newall |
We aim to develop an equity-informative economic evaluation of RSV vaccination strategies in older Australians. We will apply a distributional cost-effectiveness analyses (DCEA) approach. One of the important benefits of DCEA is that it can estimate the distributional impact of interventions across different equity relevant groups (such as socioeconomic quintiles) and provide an understanding of how an intervention may impact on equity and the magnitude of the equity impact.
Health, Equity and Autonomy: Public preferences for policy Interventions during emerging infectious disease outbreaks in Indonesia
| Duration | 2 years |
| Lead investigator | Blake Agnell |
This project aims to understand the preferences of a cohort of the Indonesian population over key trade-offs inherent in policy interventions during emerging disease outbreaks to guide policy decisions in future responses.
Modelling the Epidemiological and Equity Impacts of Ending U.S. Tuberculosis Support in Vietnam, Indonesia and the Philippines
| Duration | 2 years |
| Lead investigator | Romain Ragonnet |
This project quantifies the additional TB burden—morbidity, mortality, catastrophic costs, and inequity—resulting from the funding disruptions in Vietnam, Indonesia, and the Philippines over 2025–2035. We will also retrospectively assess U.S. TB support’s contribution over the past decade by estimating TB burden averted. Additionally, we will deliver opensource and user-friendly computational tools for study replication and broader application.
The feasibility and acceptability of methods for collecting societal costs of point of care (POC) testing for infectious disease in Aboriginal and Torres Strait Islander communities
| Duration | 2 years |
| Lead investigator | Caroline Watts |
This project aims to collect societal costs related to the management of infectious diseases, including current care and the impacts of new technologies such as point of care (POC) testing in Aboriginal and Torres Strait Islander communities. We envisage using a novel framework that includes Indigenous perspectives and established health economic costing methodologies, which aims to capture the broader cost impacts and cultural considerations around experience of and management of infectious diseases
Understanding Preferences and Willingness to Pay for HPV Vaccination to Promote Equitable Uptake in China
| Duration | 1 year |
| Lead investigator | Xinhui Wang |
The study aims to investigate factors contributing to HPV vaccine decision-making and uptake in China, with specific objectives to:
1) Quantify the importance of various determinants in vaccination decisions and measure willingness to pay (WTP);
2) Examine heterogeneity in preferences and WTP among diverse socioeconomic groups;
3) Identify the most critical vaccine attribute(s) and optimal vaccine profile for promoting equitable uptake.